(Reuters) – Merck & Co Inc (MRK.N) said on Monday it has applied for U.S. emergency use authorization for its drug to treat mild-to-moderate patients of COVID-19, putting it on course to…
Trending News
November 19, 2024
July 10, 2024
June 21, 2024
June 21, 2024